| 0 |
MYOGLOBINAEMIA |
1 |
0.0085 |
| 1 |
METASTASES TO RETROPERITONEUM |
1 |
0.0059 |
| 2 |
EPIRETINAL MEMBRANE |
1 |
0.0036 |
| 3 |
METASTATIC CARCINOMA OF THE BLADDER |
1 |
0.0028 |
| 4 |
BLADDER TRANSITIONAL CELL CARCINOMA |
4 |
0.0028 |
| 5 |
DIABETIC RETINAL OEDEMA |
1 |
0.0020 |
| 6 |
TRACHEOBRONCHITIS |
1 |
0.0013 |
| 7 |
PYURIA |
1 |
0.0010 |
| 8 |
HYPOGLYCAEMIC COMA |
2 |
0.0007 |
| 9 |
NEOPLASM SKIN |
1 |
0.0006 |
| 10 |
URINE KETONE BODY PRESENT |
1 |
0.0006 |
| 11 |
PAPILLARY THYROID CANCER |
1 |
0.0006 |
| 12 |
LYMPHADENOPATHY MEDIASTINAL |
1 |
0.0005 |
| 13 |
VITREOUS HAEMORRHAGE |
1 |
0.0004 |
| 14 |
VULVOVAGINAL MYCOTIC INFECTION |
1 |
0.0003 |
| 15 |
GASTRITIS EROSIVE |
1 |
0.0002 |
| 16 |
HAEMORRHOIDAL HAEMORRHAGE |
1 |
0.0002 |
| 17 |
CORONARY ARTERY STENOSIS |
1 |
0.0002 |
| 18 |
BLADDER CANCER |
7 |
0.0001 |
| 19 |
HAEMATURIA |
4 |
0.0001 |
| 20 |
DIABETES MELLITUS INADEQUATE CONTROL |
2 |
0.0001 |
| 21 |
ATELECTASIS |
1 |
0.0001 |
| 22 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
0.0001 |
| 23 |
PRODUCT PRESCRIBING ISSUE |
2 |
0.0001 |
| 24 |
OESOPHAGITIS |
1 |
0.0001 |
| 25 |
MITRAL VALVE INCOMPETENCE |
1 |
0.0001 |
| 26 |
MYOCARDIAL ISCHAEMIA |
1 |
0.0001 |
| 27 |
CARDIOMEGALY |
1 |
0.0001 |
| 28 |
PEMPHIGUS |
1 |
0.0001 |
| 29 |
GASTROENTERITIS |
1 |
0.0001 |
| 30 |
HEPATIC FAILURE |
2 |
0.0001 |
| 31 |
SCIATICA |
1 |
0.0001 |
| 32 |
COLD SWEAT |
1 |
0.0001 |
| 33 |
DRUG ERUPTION |
1 |
0.0001 |
| 34 |
FOOT FRACTURE |
1 |
0.0001 |
| 35 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 36 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 37 |
HAEMORRHOIDS |
1 |
0.0001 |
| 38 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 39 |
RETCHING |
1 |
0.0000 |
| 40 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 41 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 42 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 43 |
PNEUMONITIS |
1 |
0.0000 |
| 44 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 45 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 46 |
VERTIGO |
2 |
0.0000 |
| 47 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 48 |
CYSTITIS |
1 |
0.0000 |
| 49 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 50 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 51 |
CARDIAC FAILURE |
2 |
0.0000 |
| 52 |
OSTEOPOROSIS |
1 |
0.0000 |
| 53 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 54 |
DRY EYE |
1 |
0.0000 |
| 55 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 56 |
PANCREATITIS |
1 |
0.0000 |
| 57 |
CATARACT |
1 |
0.0000 |
| 58 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 59 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 60 |
DIABETES MELLITUS |
1 |
0.0000 |
| 61 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 62 |
COMPLETED SUICIDE |
1 |
0.0000 |
| 63 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 64 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 65 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 66 |
DYSPNOEA |
4 |
0.0000 |
| 67 |
HYPOAESTHESIA |
1 |
0.0000 |
| 68 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 69 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 70 |
PNEUMONIA |
2 |
0.0000 |
| 71 |
TREMOR |
1 |
0.0000 |
| 72 |
COVID-19 |
1 |
0.0000 |
| 73 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 74 |
CHEST PAIN |
1 |
0.0000 |
| 75 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 76 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 77 |
CONSTIPATION |
1 |
0.0000 |
| 78 |
OFF LABEL USE |
4 |
0.0000 |
| 79 |
DECREASED APPETITE |
1 |
0.0000 |
| 80 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 81 |
INSOMNIA |
1 |
0.0000 |
| 82 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 83 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 84 |
FALL |
1 |
0.0000 |
| 85 |
ASTHENIA |
1 |
0.0000 |
| 86 |
NAUSEA |
2 |
0.0000 |
| 87 |
RASH |
1 |
0.0000 |
| 88 |
MALAISE |
1 |
0.0000 |
| 89 |
VOMITING |
1 |
0.0000 |
| 90 |
DIZZINESS |
1 |
0.0000 |
| 91 |
DIARRHOEA |
1 |
0.0000 |
| 92 |
DRUG INEFFECTIVE |
2 |
0.0000 |
| 93 |
DEATH |
1 |
0.0000 |